Market Research Logo

Global Epigenetics Market - Segmented by Kits, Reagents, Enzymes, Instruments, Application, Technology, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Epigenetics Market - Segmented by Kits, Reagents, Enzymes, Instruments, Application, Technology, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global epigenetics market is estimated to grow rapidly at a CAGR of over 20% during the forecast period. Epigenetics is defined as the study of changes in gene expression, which are caused by certain base pairs in DNA, or RNA, being turned off or on again, through the chemical reactions.

Increasing Incidence and Prevalence of Cancer

According to Cancer Research UK, in 2012, 14.1 million new cases of cancer were diagnosed worldwide. The World Health Organization estimated that this figure may rise to 35 million new cases in 2035. It is also estimated that nearly 550,000 new cases are diagnosed with head and neck cancer each year, across the world. It is estimated that nearly 6% of the malignancies occur in the United States. According to the American Cancer society, nearly 40,000 people in the United States are diagnosed with head and neck cancer, of which 12,000 were supposed to die in the year 2014 alone. This depicts the large patient pool of cancer patients, which will propel the growth of the epigenetics market. The other factors, like increasing funding for R&D in healthcare and the rising epigenetic applications in non-oncology diseases, are driving the market.

Rising Cost of Instruments

The epigenetic instruments cost is rising gradually, and this increase is becoming one of the major restrains for the growth of the market. The instruments, such as mass spectrometers, sonicators, and the next generation sequences, are already costly, and the rising cost of these instruments are going to increase the cost for the genetic test, which simultaneously decreases the adoption rate of epigenetics. And the lack of skilled researchers is restraining the market growth of epigenetics.

The United States has the Highest Market Share

In North America, the United States is dominating the epigenetics market due to the factors, such as increasing prevalence rate of cancer, increasing funding for the R&D, and the increasing collaborations between several large pharmaceutical companies for development of enhanced therapeutics. Asia-Pacific is expected to record a substantial growth over the forecast period.

Key Developments in the Market

December 2017: Roche and Ignyta made definitive merger agreement
December 2017: Zymo Research collaborated with Bertin


Reasons to Purchase the Report

Current and future market outlook for epigenetics in the developed and emerging markets
Analyze various perspectives on the market, with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth, during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3-month analyst support, along with the market estimate sheet (in excel)

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Incidence and Prevalence of Cancer
6.1.2 Increasing Funding for R&D in Healthcare
6.1.3 Rising Epigenetic Applications in Non-Oncology Diseases
6.2 Market Restraints
6.2.1 Rising Cost of Instruments
6.2.2 Dearth of Skilled Researchers
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 Segmentation -by Kits
7.1.1 Bisulfite Conversion Kits
7.1.2 Chip-seq Kits
7.1.3 RNA Sequencing Market
7.1.4 Whole Genome Amplification Market
7.1.5 5-HMC and 5-MC Analysis Kits
7.1.6 Other Kits
7.2 Segmentation -by Reagents
7.2.1 Antibodies
7.2.2 Buffers
7.2.3 Histones
7.2.4 Magnetic Beads
7.2.5 Primers
7.2.6 Other Reagents
7.3 Segmentation -by Enzymes
7.3.1 DNA - Modifying Enzymes
7.3.2 Protein Modifying Enzymes
7.3.3 RNA Modifying Enzymes
7.4 Segmentation -by Instruments
7.4.1 Mass Spectrometer
7.4.2 Sonicators
7.4.3 Next Generation Sequencers
7.4.4 Others
7.5 Segmentation -by Application
7.5.1 Oncology
7.5.2 Non-Oncology Inflammatory Diseases Metabolic Diseases Infectious Diseases Cardiovascular Diseases Others
7.5.3 Developmental Biology
7.5.4 Other Research Areas
7.6 Segmentation -by Technology
7.6.1 DNA Methylation
7.6.2 Histone Methylation
7.6.3 Histone Acetylation
7.6.4 Large Noncoding RNA
7.6.5 MicroRNA modification
7.6.6 Chromatin Structures
7.7 Segmentation - by Geography
7.7.1 North America United States Canada Mexico
7.7.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
7.7.3 Asia-Pacific China Japan India Australia New Zealand South Korea Rest of Asia-Pacific
7.7.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
7.7.5 South America Brazil Argentina Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 Abcam PLC
9.2 Active Motiff
9.3 Diagenode Inc.
9.4 Illumina Inc.
9.5 Merck & Co.
9.6 Qiagen
9.7 Sigma Aldrich Corporation
9.8 Thermo Fisher Scientific
9.9 Zymo Research Corporation
9.10 Roche
9.11 Others
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report